Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Vora

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
Pediatric Blood & Cancer|January 20, 2006
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trialsRamya Ramanujachar, Sue Richards, Ian Hann, et al.
The Lancet. Oncology|June 14, 2014
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Chris Mitchell, et al.
British Journal of Haematology|March 12, 2011
Internal iliac artery pseudoaneurysm in an infant following bone marrow trephine biopsyMarc A Bailey, Nina R Farquharson, Patrick A Coughlin, et al.
BMJ (Clinical Research Ed.)|November 25, 2017
Are the risks of treatment to cure a child with severe sickle cell disease too high?Mariane de Montalembert, Valentine Brousse, Subarna Chakravorty, et al.
British Journal of Haematology|August 29, 2012
The role of routine surveillance for silent central nervous system relapse in children with acute lymphoblastic leukaemiaMette Jorgensen, Ananth Shankar, Zainul Aabideen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2010
Comparison of self-reported late effects with medical records among survivors of childhood cancerNaomi Taylor, Kate Absolom, Gisela Michel, et al.
British Journal of Haematology|January 17, 2014
Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocolKatharine Patrick, Rachel Wade, Nicholas Goulden, et al.
Archives of Disease in Childhood|February 12, 2016
Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003Jack Bartram, Rachel Wade, Ajay Vora, et al.
Blood|June 7, 2014
Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003David O'Connor, Jessica Bate, Rachel Wade, et al.
Lancet (London, England)|October 19, 2006
Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trialAjay Vora, Chris D Mitchell, Lynne Lennard, et al.
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Pediatric Blood & Cancer|January 20, 2006
Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trialsRamya Ramanujachar, Sue Richards, Ian Hann, et al.
The Lancet. Oncology|June 14, 2014
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trialAjay Vora, Nick Goulden, Chris Mitchell, et al.
British Journal of Haematology|March 12, 2011
Internal iliac artery pseudoaneurysm in an infant following bone marrow trephine biopsyMarc A Bailey, Nina R Farquharson, Patrick A Coughlin, et al.
BMJ (Clinical Research Ed.)|November 25, 2017
Are the risks of treatment to cure a child with severe sickle cell disease too high?Mariane de Montalembert, Valentine Brousse, Subarna Chakravorty, et al.
British Journal of Haematology|August 29, 2012
The role of routine surveillance for silent central nervous system relapse in children with acute lymphoblastic leukaemiaMette Jorgensen, Ananth Shankar, Zainul Aabideen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2010
Comparison of self-reported late effects with medical records among survivors of childhood cancerNaomi Taylor, Kate Absolom, Gisela Michel, et al.
British Journal of Haematology|January 17, 2014
Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocolKatharine Patrick, Rachel Wade, Nicholas Goulden, et al.
Archives of Disease in Childhood|February 12, 2016
Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003Jack Bartram, Rachel Wade, Ajay Vora, et al.
Blood|June 7, 2014
Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003David O'Connor, Jessica Bate, Rachel Wade, et al.
Lancet (London, England)|October 19, 2006
Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trialAjay Vora, Chris D Mitchell, Lynne Lennard, et al.
Pageof 17